Clinical trial
Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast…
NCT00290732 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00290732 |
|---|---|
| Title | Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer |
| Official title | A Phase I Study Assessing the Feasibility and Safety of Intraductal Administration of Pegylated Liposomal Doxorubicin (Doxil) in Women With Breast Cancer |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Intraductal arm, Intravenous arm |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2011 |
| Completion | Oct 1, 2011 |
| First posted | Feb 13, 2006 |
| Last update posted | Oct 31, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: